-
Publications
-
Meetings
-
Education
-
About
-
Resources
Advertisement
ADVERTISEMENT
PolarityTE announced the company has secured $22.5MM in financing to advance SkinTE Phase III Pivotal Study in DFUs. COVER DFUS II will enroll up to 120 patients at up to 20 clinical sites in the US. The primary endpoint is percent DFUs closed at 12 weeks.
Advertisement
Advertisement
Advertisement